The aim of our study was to investigate antiproliferative effects of PEP005 in a panel of colon cancer cell lines that expressed various levels of PKCδ and to evaluate the effects of PEP005-based combinations with cytotoxic agents commonly used for the treatment of cancer. Here, PRKCD is linked to colonic neoplasm.